These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38484878)

  • 1. Deep transcranial magnetic stimulation for adolescents with treatment-resistant depression: A preliminary dose-finding study exploring safety and clinical effectiveness.
    Thai M; Nair AU; Klimes-Dougan B; Albott CS; Silamongkol T; Corkrum M; Hill D; Roemer JW; Lewis CP; Croarkin PE; Lim KO; Widge AS; Nahas Z; Eberly LE; Cullen KR
    J Affect Disord; 2024 Jun; 354():589-600. PubMed ID: 38484878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
    Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
    World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder.
    Wall CA; Croarkin PE; Maroney-Smith MJ; Haugen LM; Baruth JM; Frye MA; Sampson SM; Port JD
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):582-9. PubMed ID: 26849202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seizure Induced by Deep Transcranial Magnetic Stimulation in an Adolescent with Depression.
    Cullen KR; Jasberg S; Nelson B; Klimes-Dougan B; Lim KO; Croarkin PE
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):637-41. PubMed ID: 27447245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study.
    Tendler A; Gersner R; Roth Y; Zangen A
    J Affect Disord; 2018 Nov; 240():130-136. PubMed ID: 30071416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation.
    Seewoo BJ; Rodger J; Demitrack MA; Heart KL; Port JD; Strawn JR; Croarkin PE
    Int J Neuropsychopharmacol; 2022 Aug; 25(8):619-630. PubMed ID: 35089358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EEG synchronized left prefrontal transcranial magnetic stimulation (TMS) for treatment resistant depression is feasible and produces an entrainment dependent clinical response: A randomized controlled double blind clinical trial.
    George MS; Huffman S; Doose J; Sun X; Dancy M; Faller J; Li X; Yuan H; Goldman RI; Sajda P; Brown TR
    Brain Stimul; 2023; 16(6):1753-1763. PubMed ID: 38043646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.
    McGirr A; Van den Eynde F; Chachamovich E; Fleck MP; Berlim MT
    Neurosci Lett; 2014 Mar; 563():144-8. PubMed ID: 24486892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural correlates of clinical improvement after deep transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a case report using functional magnetic resonance imaging.
    Harvey PO; Van den Eynde F; Zangen A; Berlim MT
    Neurocase; 2015 Feb; 21(1):16-22. PubMed ID: 24313336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression.
    Feffer K; Lapidus KAB; Braw Y; Bloch Y; Kron S; Netzer R; Nitzan U
    Eur Psychiatry; 2017 Jul; 44():61-67. PubMed ID: 28545010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of deep transcranial magnetic stimulation for treatment-resistant depression: A systematic review and meta-analysis.
    Hung YY; Yang LH; Stubbs B; Li DJ; Tseng PT; Yeh TC; Chen TY; Liang CS; Chu CS
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109850. PubMed ID: 31863873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex in depressive episodes of patients with major depressive disorder, bipolar disorder I, and major depressive with alcohol use disorders.
    Rapinesi C; Kotzalidis GD; Ferracuti S; Girardi N; Zangen A; Sani G; Raccah RN; Girardi P; Pompili M; Del Casale A;
    Neurosci Lett; 2018 Apr; 671():128-132. PubMed ID: 29454034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
    Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
    Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Bipolar Depression with Deep TMS: Results from a Double-Blind, Randomized, Parallel Group, Sham-Controlled Clinical Trial.
    Tavares DF; Myczkowski ML; Alberto RL; Valiengo L; Rios RM; Gordon P; de Sampaio-Junior B; Klein I; Mansur CG; Marcolin MA; Lafer B; Moreno RA; Gattaz W; Daskalakis ZJ; Brunoni AR
    Neuropsychopharmacology; 2017 Dec; 42(13):2593-2601. PubMed ID: 28145409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression.
    Cole EJ; Stimpson KH; Bentzley BS; Gulser M; Cherian K; Tischler C; Nejad R; Pankow H; Choi E; Aaron H; Espil FM; Pannu J; Xiao X; Duvio D; Solvason HB; Hawkins J; Guerra A; Jo B; Raj KS; Phillips AL; Barmak F; Bishop JH; Coetzee JP; DeBattista C; Keller J; Schatzberg AF; Sudheimer KD; Williams NR
    Am J Psychiatry; 2020 Aug; 177(8):716-726. PubMed ID: 32252538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients.
    Levkovitz Y; Harel EV; Roth Y; Braw Y; Most D; Katz LN; Sheer A; Gersner R; Zangen A
    Brain Stimul; 2009 Oct; 2(4):188-200. PubMed ID: 20633419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot investigation of accelerated deep transcranial magnetic stimulation protocols in treatment-resistant depression.
    Filipčić I; Šimunović Filipčić I; Sučić S; Milovac Ž; Gereš N; Matić K; Čelić-Ružić M; Zečević Penić S; Orgulan I; Požgaj V; Bajić Ž
    Eur Arch Psychiatry Clin Neurosci; 2021 Feb; 271(1):49-59. PubMed ID: 32449010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of deep transcranial magnetic stimulation on insomnia outcomes in patients with treatment-resistant depression: a retrospective study.
    Chopra A; Singal P; Kodya S
    J Clin Sleep Med; 2024 May; 20(5):813-815. PubMed ID: 38152858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.